Peter Hanfland

3.0k total citations
81 papers, 2.2k citations indexed

About

Peter Hanfland is a scholar working on Molecular Biology, Hematology and Physiology. According to data from OpenAlex, Peter Hanfland has authored 81 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 29 papers in Hematology and 25 papers in Physiology. Recurrent topics in Peter Hanfland's work include Glycosylation and Glycoproteins Research (32 papers), Erythrocyte Function and Pathophysiology (17 papers) and Carbohydrate Chemistry and Synthesis (17 papers). Peter Hanfland is often cited by papers focused on Glycosylation and Glycoproteins Research (32 papers), Erythrocyte Function and Pathophysiology (17 papers) and Carbohydrate Chemistry and Synthesis (17 papers). Peter Hanfland collaborates with scholars based in Germany, United States and United Kingdom. Peter Hanfland's co-authors include Heinz Egge, J. Da̧browski, Ursula Dąbrowski, Maria Kordowicz, Ten Feizi, Jasna Peter‐Katalinić, Wilhelm Stoffel, Johannes Oldenburg, R. Schwaab and Keiichi Uemura and has published in prestigious journals such as Journal of Biological Chemistry, Neurology and Biochemistry.

In The Last Decade

Peter Hanfland

80 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Hanfland Germany	30	1.4k	543	459	419	305	81	2.2k
Jerzy Kościelak Poland	21	1.2k 0.9×	515 0.9×	311 0.7×	284 0.7×	508 1.7×	78	1.6k
Franca Serafini‐Cessi Italy	30	1.3k 0.9×	314 0.6×	117 0.3×	487 1.2×	114 0.4×	73	2.2k
Theodore A.W. Koerner United States	24	764 0.6×	408 0.8×	237 0.5×	151 0.4×	147 0.5×	59	1.7k
William J. Kuhns United States	22	638 0.5×	257 0.5×	210 0.5×	391 0.9×	167 0.5×	89	1.3k
J.M. McKibbin United States	21	950 0.7×	270 0.5×	158 0.3×	170 0.4×	206 0.7×	33	1.3k
Nadia Malagolini Italy	30	1.7k 1.2×	332 0.6×	83 0.2×	711 1.7×	117 0.4×	75	2.4k
H. Haupt Germany	30	1.2k 0.9×	99 0.2×	347 0.8×	381 0.9×	200 0.7×	83	2.4k
Marian Gorecki Israel	31	971 0.7×	78 0.1×	214 0.5×	240 0.6×	178 0.6×	63	2.2k
Ganesa Yogeeswaran United States	22	1.3k 1.0×	208 0.4×	98 0.2×	546 1.3×	96 0.3×	38	2.0k
Makoto Asada Japan	21	1.3k 0.9×	388 0.7×	75 0.2×	327 0.8×	124 0.4×	49	2.8k

Countries citing papers authored by Peter Hanfland

Since Specialization

Citations

This map shows the geographic impact of Peter Hanfland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hanfland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hanfland more than expected).

Fields of papers citing papers by Peter Hanfland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hanfland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hanfland. The network helps show where Peter Hanfland may publish in the future.

Co-authorship network of co-authors of Peter Hanfland

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hanfland. A scholar is included among the top collaborators of Peter Hanfland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hanfland. Peter Hanfland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gao, Chao, Yan Liu, Hongtao Zhang, et al.. (2014). Carbohydrate Sequence of the Prostate Cancer-associated Antigen F77 Assigned by a Mucin O-Glycome Designer Array. Journal of Biological Chemistry. 289(23). 16462–16477. 38 indexed citations

Müller, Jens, Anna Maria Eis‐Hübinger, Martin Däumer, et al.. (2007). A novel internally controlled real-time reverse transcription-PCR assay for HIV-1 RNA targeting the pol integrase genomic region. Journal of Virological Methods. 142(1-2). 127–135. 17 indexed citations

Ivaškevičius, Vytautas, Michael Steffens, Christof Geisen, et al.. (2005). γAla82Gly represents a common fibrinogen γ-chain variant in Caucasians. Blood Coagulation & Fibrinolysis. 16(3). 205–208. 7 indexed citations

El‐Maarri, Osman, Jochen Graw, Jörg Schröder, et al.. (2005). Analysis of mRNA in hemophilia A patients with undetectable mutations reveals normal splicing in the factor VIII gene. Journal of Thrombosis and Haemostasis. 3(2). 332–339. 62 indexed citations

Hanfland, Peter, et al.. (2005). Development, validation and evaluation of a homogenous one-step reverse transcriptase-initiated PCR assay with competitive internal control for the detection of hepatitis C virus RNA. Clinical Chemistry and Laboratory Medicine (CCLM). 43(8). 827–33. 9 indexed citations

Siekmeier, R., et al.. (2004). Uptake of Magnetic Beads by Dendritic Cells, a Major Obstacle for the Use of Beads in Biological Assays. Acta Haematologica. 112(3). 172–176. 3 indexed citations

Albert, T., Johannes Oldenburg, Peter Hanfland, et al.. (2003). Regulation of human factor IX expression using doxycycline-inducible gene expression system. Thrombosis and Haemostasis. 90(9). 398–405. 10 indexed citations

Oldenburg, Johannes, et al.. (2000). Molecular Genetics in Haemophilia A. Vox Sanguinis. 78(S2). 33–38. 3 indexed citations

Hofmann, Axel, Peter Hanfland, & Walter Maier. (2000). Malaria und Blutspende: Sind Dauersperren gerechtfertigt?. Transfusion Medicine and Hemotherapy. 27(1). 5–14. 1 indexed citations

10.

Oldenburg, Johannes, Andreas Fregin, Wolfram Kreß, et al.. (1997). Missense mutations at ALA‐10 in the factor IX propeptide: an insignificant variant in normal life but a decisive cause of bleeding during oral anticoagulant therapy. British Journal of Haematology. 98(1). 240–244. 60 indexed citations

11.

Oldenburg, Johannes, et al.. (1996). Eigenschaften und Indikationen von PPSB-Konzentraten unter besonderer Berücksichtigung der Qualitätssicherung sowie flankierender therapeutischer Maßnahmen. Transfusion Medicine and Hemotherapy. 23(6). 271–280. 1 indexed citations

12.

Kroll, H., V. Kiefel, G. Giers, et al.. (1994). Maternal intravenous immunoglobulin treatment does not prevent intracranial haemorrhage in fetal alloimmune thrombocytopenia. Transfusion Medicine. 4(4). 293–296. 57 indexed citations

13.

Scharf, Rüdiger E. & Peter Hanfland. (1993). Platelet storage lesions: Analysis of platelet membrane glycoproteins and platelet-derived microparticles by fluorescence-activated flow cytometry. Transfusion Science. 14(2). 189–194. 10 indexed citations

14.

Stoll, Mark S., et al.. (1991). Studies of the binding specificity of the soluble 14 000-dalton bovine heart muscle lectin using immobilised glycolipids and neoglycolipids. Carbohydrate Research. 213. 293–307. 38 indexed citations

15.

Hanfland, Peter, Maria Kordowicz, Jasna Peter‐Katalinić, et al.. (1988). Structure elucidation of blood group B-like and I-active ceramide eicosa- and pentacosa-saccharides from rabbit erythrocyte membranes by combined gas chromatography-mass spectrometry; electron-impact and fast-atom-bombardment mass spectrometry; and two-dimensional correlated, relayed-coherence transfer, and nuclear overhauser effect 500-MHz 1H-N.m.r. spectroscopy. Carbohydrate Research. 178(1). 1–21. 35 indexed citations

16.

Da̧browski, J., Ursula Dąbrowski, Wolfgang Bermel, Maria Kordowicz, & Peter Hanfland. (1988). Structure elucidation of the blood group B like and blood group I active octaantennary ceramide tetracontasaccharide from rabbit erythrocyte membranes by two-dimensional proton NMR spectroscopy at 600 MHz. Biochemistry. 27(14). 5149–5155. 23 indexed citations

17.

Da̧browski, J., Peter Hanfland, Heinz Egge, & Ursula Dąbrowski. (1981). Immunochemistry of the Lewis-blood-group system: Proton nuclear magnetic resonance study of plasmatic Lewis-blood-group-active glycosphingolipids and related substances. Archives of Biochemistry and Biophysics. 210(1). 405–411. 76 indexed citations

18.

Hanfland, Peter & G Uhlenbruck. (1978). [Topical immunochemical consideration of the structure of the tumour cell membrane (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 16(2). 85–101. 4 indexed citations

19.

Hanfland, Peter, Gerd Assmann, & Heinz Egge. (1978). Enzymatic Determination of the Anomeric Structures of Two Blood-Group B Active Glycosphingolipids Recombined with Apolipoproteins. Zeitschrift für Naturforschung C. 33(1-2). 73–78. 4 indexed citations

20.

Hanfland, Peter, R.G. Kladetzky, & H. Egli. (1978). Isolation and purification of Lea blood-group active and related glycolipids from human plasma of blood-group A Lea individuals. Chemistry and Physics of Lipids. 22(2). 141–151. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact